Filing Details
- Accession Number:
- 0001181431-10-041134
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-10 13:00:00
- Reporting Period:
- 2010-08-06
- Filing Date:
- 2010-08-10
- Accepted Time:
- 2010-08-10 14:07:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1356857 | Trius Therapeutics Inc | TSRX | Pharmaceutical Preparations (2834) | 201320630 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024008 | S David Kabakoff | C/O Trius Therapeutics, Inc. 6310 Nancy Ridge Drive, Suite 101 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-08-06 | 5,285 | $0.00 | 5,285 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2010-08-06 | 4,570 | $0.00 | 4,570 | No | 4 | C | Indirect | By Trust |
| Common Stock | Acquisiton | 2010-08-06 | 30,000 | $5.00 | 34,570 | No | 4 | P | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See Footnote |
| No | 4 | C | Indirect | By Trust |
| No | 4 | P | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Convertible Preferred Stock | Disposition | 2010-08-06 | 45,454 | $0.00 | 45,454 | $0.00 |
| Common Stock | Series A-1 Convertible Preferred Stock | Disposition | 2010-08-06 | 14,304 | $0.00 | 14,304 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2010-08-06 | 25,000 | $0.00 | 25,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 41,860 | Direct |
Footnotes
- Upon the closing of the Issuer's initial public offering, each 8.6 shares of the Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into one share of Common Stock, and had no expiration date.
- By Strategy Advisors, LLC Defined Benefit Plan, of which the reporting person has sole voting and investment power.
- By The David S. & Susan O. Kabakoff Family Trust dated 2/24/00.
Billionaire Hedge Funds
